162 related articles for article (PubMed ID: 35141223)
1. Methylation-Driven Gene PLAU as a Potential Prognostic Marker for Differential Thyroid Carcinoma.
Wu M; Wei B; Duan SL; Liu M; Ou-Yang DJ; Huang P; Chang S
Front Cell Dev Biol; 2022; 10():819484. PubMed ID: 35141223
[No Abstract] [Full Text] [Related]
2. Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma.
Lv L; Cao L; Hu G; Shen Q; Wu J
Front Genet; 2020; 11():294. PubMed ID: 32296463
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene
Ju G; Zhang L; Guo W; Wang H; Zhang X; Mu Z; Sun Y; Sun D; Diao H; Miao S; Chen Y; Xing T; Liang J; Lin Y
Dis Markers; 2022; 2022():1686316. PubMed ID: 37223105
[TBL] [Abstract][Full Text] [Related]
4. LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.
Wang J; Zhao H; Dong H; Zhu L; Wang S; Wang P; Ren Q; Zhu H; Chen J; Lin Z; Cheng Y; Qian B; Zhang Y; Jia R; Wu W; Lu J; Tan J
J Cancer; 2019; 10(26):6726-6737. PubMed ID: 31777602
[No Abstract] [Full Text] [Related]
5. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
6. Exploration of methylation-driven genes for monitoring and prognosis of patients with lung adenocarcinoma.
Gao C; Zhuang J; Li H; Liu C; Zhou C; Liu L; Sun C
Cancer Cell Int; 2018; 18():194. PubMed ID: 30498398
[TBL] [Abstract][Full Text] [Related]
7. Hypomethylation and downregulation of miR-23b-3p are associated with upregulated PLAU: a diagnostic and prognostic biomarker in head and neck squamous cell carcinoma.
Huo Z; Li X; Zhou J; Fan Y; Wang Z; Zhang Z
Cancer Cell Int; 2021 Oct; 21(1):564. PubMed ID: 34702271
[TBL] [Abstract][Full Text] [Related]
8. Identification of epigenetic methylation-driven signature and risk loci associated with survival for colon cancer.
Wang X; Zhang D; Zhang C; Sun Y
Ann Transl Med; 2020 Mar; 8(6):324. PubMed ID: 32355768
[TBL] [Abstract][Full Text] [Related]
9. Prognostic values of m6A RNA methylation regulators in differentiated Thyroid Carcinoma.
Xu N; Chen J; He G; Gao L; Zhang D
J Cancer; 2020; 11(17):5187-5197. PubMed ID: 32742465
[TBL] [Abstract][Full Text] [Related]
10. Screening of key methylation-driven genes CDO1 in breast cancer based on WGCNA.
Tu S; Zhang H; Qu X
Cancer Biomark; 2022; 34(4):571-582. PubMed ID: 35342080
[TBL] [Abstract][Full Text] [Related]
11. CTSK and PLAU as Prognostic Biomarker and Related to Immune Infiltration in Pancreatic Cancer: Evidence from Bioinformatics Analysis and qPCR.
Ding Y; Li Z; Wang H; Wang Q; Jiang H; Yu Z; Xu M
Int J Genomics; 2023; 2023():3914687. PubMed ID: 38077303
[TBL] [Abstract][Full Text] [Related]
12. Exploration of DNA Methylation-Driven Genes in Papillary Thyroid Carcinoma Based on the Cancer Genome Atlas.
Chen Y; Wang K; Shang M; Zhao S; Zhang Z; Yang H; Chen Z; Du R; Wang Q; Chen B
J Comput Biol; 2021 Jan; 28(1):99-114. PubMed ID: 32790501
[TBL] [Abstract][Full Text] [Related]
13. Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas.
Liu Z; Wan Y; Yang M; Qi X; Dong Z; Huang J; Xu J
Cancer Cell Int; 2020; 20():235. PubMed ID: 32536823
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.
Li R; Yin YH; Jin J; Liu X; Zhang MY; Yang YE; Qu YQ
Int J Med Sci; 2020; 17(6):773-786. PubMed ID: 32218699
[No Abstract] [Full Text] [Related]
15. Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
Xu N; Wu YP; Ke ZB; Liang YC; Cai H; Su WT; Tao X; Chen SH; Zheng QS; Wei Y; Xue XY
J Transl Med; 2019 Sep; 17(1):311. PubMed ID: 31533842
[TBL] [Abstract][Full Text] [Related]
16. Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas.
Lu T; Chen D; Wang Y; Sun X; Li S; Miao S; Wo Y; Dong Y; Leng X; Du W; Jiao W
Cancer Cell Int; 2019; 19():52. PubMed ID: 30886542
[TBL] [Abstract][Full Text] [Related]
17. Development of Potential Prognostic Biomarkers Based on DNA Methylation-Driven Genes for Patients with Endometrial Cancer.
Lu Y; Tang W; Wang X; Kang X; You J; Chen L
Int J Gen Med; 2021; 14():10541-10555. PubMed ID: 35002309
[TBL] [Abstract][Full Text] [Related]
18. Identification of 4-methylation driven genes based prognostic signature in thyroid cancer: an integrative analysis based on the methylmix algorithm.
Chen Z; Liu X; Liu F; Zhang G; Tu H; Lin W; Lin H
Aging (Albany NY); 2021 Aug; 13(16):20164-20178. PubMed ID: 34456184
[TBL] [Abstract][Full Text] [Related]
19. Analysis of methylation-driven genes for predicting the prognosis of patients with head and neck squamous cell carcinoma.
Pan Y; Song Y; Cheng L; Xu H; Liu J
J Cell Biochem; 2019 Dec; 120(12):19482-19495. PubMed ID: 31264288
[TBL] [Abstract][Full Text] [Related]
20. Prognostic biomarker identification and tumor classification in breast cancer patients by methylation and transcriptome analysis.
Zhong X; Zhong G
FEBS Open Bio; 2021 Aug; 11(8):2139-2151. PubMed ID: 34056873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
